Compare Globus Medical Inc. Class A Common Stock (GMED) vs Atlassian Corporation PLC (TEAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Atlassian Corporation PLC — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Atlassian Corporation PLC trades at $203.6 (market cap $51.81B). The key difference: Atlassian Corporation PLC is far larger — about 5.1× Globus Medical Inc. Class A Common Stock's market cap, and Atlassian Corporation PLC is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Atlassian Corporation PLC for 65 Days on average.
| GMED | TEAM | |
|---|---|---|
Market Cap | $10.25B | $51.81B |
Volume | 1,059,528 | 2,082,521 |
Sector | Health | Technology |
52-Week High | $96.82 | $208.04 |
52-Week Low | $58.33 | $57.15 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $9.76B | $51.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Atlassian (TEAM) trades at $208.04, up 0.14% on the day, with strong technical momentum and consistent earnings beats. The stock shows bullish moving average signals despite an overbought RSI near 83. Revenue growth has accelerated from $2.8B in 2022 to $5.2B in 2025, though the company remains unprofitable with a -0.82% net margin. Recent news highlights AI-driven product adoption and cloud migration progress as key growth catalysts.
Outlook remains positive with 70% analyst buy ratings and a $140B addressable market, but high valuations (P/S 8.24, EV/EBITDA 248.18) and persistent losses pose risks. The consensus price target of $197.47 suggests modest downside from current levels, requiring careful monitoring of profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Atlassian Corporation PLC
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →
